ARCS Weekly Wrap 12 September 2025

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a1/cc/9a/a1cc9a9e-a4bc-39aa-92d3-3cf6d0ab2b14/mza_15551501372172170772.jpg/600x600bb.jpg

Cognitio

ARCS Australia

27 episodes

3 days ago

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

Medicine

Health & Fitness

RSS

All content for Cognitio is the property of ARCS Australia and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43238377/43238377-1741754321693-fbfa5331b1537.jpg

ARCS Weekly Wrap 12 September 2025

Cognitio

5 minutes 16 seconds

1 month ago

ARCS Weekly Wrap 12 September 2025

This week’s ARCS Biopharma & Medtech Wrap dives into the biggest headlines shaping the life sciences sector – from pharma restructures and drug pricing debates to medtech innovation and Australian biotech success stories.

We cover:

Pharma: Novo Nordisk’s 9,000 job cuts, Lundbeck’s global exits, Takeda’s narcolepsy breakthrough, and the growing debate on PBS and international drug pricing.
Medtech: A $160m investment in robotics and AI in Sydney, plus Professor Edward Holmes’ award-winning AI and genomics research.
Biotech & Investment: Cartherics and HaemaLogiX shine at the Asia Pacific Cell & Gene Awards, while local biotechs secure funding and approvals.
People Movement: Leadership changes at Novartis and BeOne, and Daiichi Sankyo’s recognition as a top employer.

We’ll unpack what it means for you – from clinicians and researchers to policy specialists and industry leaders. Plus, we connect the dots to upcoming ARCS events: the Leadership & Communication Symposium (18 Sept, Sydney) and the Global Cell & Gene Summit (25 Feb 2026, Sydney).

🎧 Tune in for insights, context, and commentary on the news that matters to Australia’s life sciences community.

👉 Join the conversation. Join ARCS today: arcs.com.au